Published in Cancer Weekly, April 15th, 2008
"The method of immunization will confer significant properties to the potency of the vaccine and might require augmentation with certain adjuvant agents like interieukin-12 and granulocyte-macrophage colony-stimulating...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.